semaglutide news october 2025 Tirzepatide Tops for Weight Loss: SURMOUNT-5 Semaglutide Market Size, Share &

A provider has pointed out, The biggest challenge is deciding whether to prescribe medication for patients with BMI near the 30% cutoff, as small variations in weight can significantly impact eligibility. Ethical dilemmas arise when patient expectations are set too high, balancing clinical appropriateness with patient expectations when data foundations are not trustworthy

Shrinking appetites, smaller tabs and shifting risks for restaurant-heavy portfolios Fast-food chains face a quiet but mounting threat from GLP-1 weight-loss drugs as millions of Canadians shrink their appetites and rethink what counts as a treat, according to The Canadian Press

Ozempic works primarily by mimicking the hormone GLP-1, which is naturally produced in the body

Data represented as the mean SEM

Retatrutide cannot be produced at a 503B facility for the same reason it cannot be produced at a 503A pharmacy

They dont rely on artificially suppressing hunger or boosting energy through stimulants